Regeneron Pharmaceuticals: EYLEA Franchise, Dupixent Immunology, and Drug Pipeline
Regeneron Pharmaceuticals is a biotech leader built on proprietary antibody technology (VelociSuite). This explainer covers the EYLEA/EYLEA HD ophthalmology franchise, Dupixent immunology partnership with Sanofi, Libtayo oncology, pipeline diversification into obesity and gene therapy, and key risks.
May 26, 2026
